Global Intrauterine Devices (IUDs) Market Size By Type (Hormonal Intrauterine Devices, Copper Intrauterine Devices), By Application (Hospital, Clinic), By Region, And Segment Forecasts, 2023 to 2032

The Global Intrauterine Devices (IUDs) Market was valued at USD 4.5 billion in 2023 and is projected to reach USD 7.8 billion by 2031, growing at a CAGR of 6.9% during the forecast period from 2023 to 2031. The increasing preference for long-acting reversible contraceptives (LARCs), advancements in IUD technology, and growing awareness about effective birth control methods are key factors propelling market growth. The demand for hormonal and non-hormonal IUDs is rising globally, with developing regions witnessing increasing adoption due to family planning initiatives by governments and non-governmental organizations (NGOs).

Market Drivers

Rising Awareness and Acceptance of Long-Acting Reversible Contraceptives (LARCs)

IUDs offer a highly effective, long-term contraceptive solution, reducing the chances of unintended pregnancies significantly.

Growing healthcare initiatives promoting contraceptive use and family planning contribute to the rising adoption of IUDs.

Technological Advancements in IUDs

New-generation IUDs, such as copper-based and hormonal devices with controlled release mechanisms, provide enhanced efficacy with minimal side effects.

The development of low-dose hormonal IUDs and frameless IUDs is gaining traction in the market.

Government-Led Family Planning Programs

Many governments, particularly in developing economies, are running awareness campaigns and providing subsidies for IUDs to promote birth control.

Organizations such as the World Health Organization (WHO) and United Nations Population Fund (UNFPA) actively promote the use of IUDs in low-income regions.

Market Restraints

Risk of Side Effects and Complications

Some users experience side effects such as cramping, irregular bleeding, and pelvic inflammatory disease (PID), which may discourage adoption.

Fear of pain during insertion also limits IUD acceptance in certain regions.

Limited Awareness in Rural and Underdeveloped Areas

Although IUDs are highly effective, misinformation and cultural taboos restrict their use in some low-income and religiously conservative communities.

The lack of trained healthcare providers to properly insert IUDs is another major limitation.

Market Opportunities

Expansion of IUD Use in Emerging Markets

The Asia-Pacific and African regions present untapped market potential due to increasing awareness of birth control.

Government initiatives supporting free or subsidized IUD distribution are expected to boost demand.

Rising Demand for Hormonal IUDs

Hormonal IUDs are gaining popularity due to their additional health benefits, such as reducing menstrual pain and treating endometriosis.

Companies are developing lower-dose and longer-lasting hormonal IUDs, which could expand their market penetration.

E-Commerce and Online Consultations Boosting IUD Access

The rise of telemedicine and online pharmacies is improving IUD accessibility, particularly in regions where direct access to contraceptive counseling is limited.

Market Segmentation Insights

Market by Type

Hormonal IUDs

Market leaders: Mirena, Kyleena, Skyla (by Bayer), Liletta (by AbbVie)

Increasing preference due to benefits like lighter periods and hormone-controlled contraception.

Non-Hormonal (Copper) IUDs

Market leaders: ParaGard (by Cooper Surgical)

Preferred by women looking for hormone-free birth control options.

Market by End-Use

Hospitals & Clinics

Account for the largest market share, as most IUD insertions occur in medical facilities.

Family Planning Centers

Government-backed and NGO-supported initiatives drive this segment.

Online & Retail Pharmacies

Increasing due to home-delivery contraceptive services and telehealth consultations.

Regional Insights

North America

Largest market share due to high awareness, insurance coverage for contraceptives, and FDA-approved product availability.

Bayer and Cooper Surgical dominate the regional market.

Europe

Significant growth with increasing adoption of hormonal IUDs and government support for contraceptive access.

Countries like Germany, the UK, and France lead in IUD use.

Asia-Pacific

Fastest-growing market due to increasing awareness, government initiatives, and growing population.

Countries such as India and China are witnessing increased IUD adoption due to family planning programs.

Latin America and the Middle East & Africa (MEA)

Growing government and NGO efforts to promote IUD use.

Limited access to trained professionals still restricts growth in rural areas.

Competitive Landscape

Key Players:

Bayer AG

Cooper Surgical, Inc.

AbbVie Inc.

DKT International

Medicines360

Merck & Co., Inc.

Pfizer Inc.

Mona Lisa N.V.

Pregna International Ltd.

Ocon Medical Ltd.

Key Market Developments:

2023: Bayer AG launched a new low-dose hormonal IUD aimed at reducing side effects and expanding market accessibility.

2023: Cooper Surgical expanded its production of ParaGard, a hormone-free IUD, to meet increasing global demand.

2024: DKT International launched affordable IUDs in underdeveloped countries in partnership with family planning NGOs.

2024: Pfizer Inc. collaborated with healthcare providers to improve IUD awareness through digital marketing campaigns.

Scope of Work – Global Intrauterine Devices (IUDs) Market

Report Metric Details

Market Size (2023) USD 4.5 billion

Projected Market Size (2031) USD 7.8 billion

CAGR (2023-2031) 6.9%

Market Segments By Type (Hormonal, Copper); By End-Use (Hospitals, Family Planning Centers, Pharmacies)

Growth Drivers Rising demand for LARCs, government family planning initiatives, new IUD innovations

Opportunities Emerging markets, demand for hormonal IUDs, online contraceptive access

FAQs

What is the current market size of the Global Intrauterine Devices (IUDs) Market?

The market was valued at USD 4.5 billion in 2023.

What is the major growth driver of the Global Intrauterine Devices (IUDs) Market?

The increasing adoption of long-acting reversible contraceptives (LARCs) and technological advancements in IUDs.

Which is the largest region during the forecast period in the Global Intrauterine Devices (IUDs) Market?

North America leads due to high awareness and healthcare support, while Asia-Pacific is the fastest-growing region.

Which segment accounted for the largest market share in the Global Intrauterine Devices (IUDs) Market?

Hormonal IUDs dominate the market due to increasing consumer preference for controlled-release contraceptive solutions.

Who are the key market players in the Global Intrauterine Devices (IUDs) Market?

Leading companies include Bayer AG, Cooper Surgical, AbbVie, DKT International, and Pfizer Inc.

This comprehensive, data-driven market report provides a deep dive into the IUD industry, covering trends, opportunities, key players, and regional insights.